Erythropoietin attenuates pulmonary vascular remodeling in experimental pulmonary arterial hypertension through interplay between endothelial progenitor cells and heme-oxygenase

Article English OPEN
Rosa L.E. Loon; Beatrijs eBartelds; Beatrijs eBartelds; Frank A.D.T.G. Wagener; Nada eAffara; Saffloer eMohaupt; Hans eWijnberg; Sebastiaan W.C. Pennings; Janny eTakens; Rolf M.F. Berger; Rolf M.F. Berger;
(2015)

BackgroundPulmonary arterial hypertension (PAH) is a pulmonary vascular disease with a high mortality, characterized by typical angio-proliferative lesions. Erythropoietin (EPO) attenuates pulmonary vascular remodeling in PAH. We postulated that EPO acts through mobiliz... View more
Share - Bookmark